General Information


DRAVP ID  DRAVPe00702

Peptide Name   Indolicidin [P3,7,10A,R12,13P]

Sequence  ILAWKWAWWAWPP

Sequence Length  13

UniProt ID  No entry found

Source  Synthetic construct(derived from Indolicidin)



Activity Information


Target Organism  HIV

Assay  HIV-1 integrase inhibition assay

Activity 

  • [Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=54 µM);inhibition of strand transfer catalyzed by integrase(IC50=41 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  HIV Integrase

Mechanism  The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00702

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Amidtion

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C92H115N19O14

Absent amino acids  CDEFGHMNQRSTVY

Common amino acids  W

Mass  1711.04

Pl  8.75

Basic residues  1

Acidic residues  0

Hydrophobic residues  10

Net charge  1

Boman Index  2137

Hydrophobicity  16.15

Aliphatic Index  83.08

Half Life 

  •     Mammalian:20 hour
  •     Yeast:30 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  27500

Absorbance 280nm  2291.67

Polar residues  0



Literature Information


Literature 1

Title   Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.

Pubmed ID   15482931

Reference   Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.

Author   Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. 

DOI   10.1016/j.bmcl.2004.08.061